Your browser doesn't support javascript.
loading
Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nik-Zainal, Serena; Davies, Helen; Staaf, Johan; Ramakrishna, Manasa; Glodzik, Dominik; Zou, Xueqing; Martincorena, Inigo; Alexandrov, Ludmil B; Martin, Sancha; Wedge, David C; Van Loo, Peter; Ju, Young Seok; Smid, Marcel; Brinkman, Arie B; Morganella, Sandro; Aure, Miriam R; Lingjærde, Ole Christian; Langerød, Anita; Ringnér, Markus; Ahn, Sung-Min; Boyault, Sandrine; Brock, Jane E; Broeks, Annegien; Butler, Adam; Desmedt, Christine; Dirix, Luc; Dronov, Serge; Fatima, Aquila; Foekens, John A; Gerstung, Moritz; Hooijer, Gerrit K J; Jang, Se Jin; Jones, David R; Kim, Hyung-Yong; King, Tari A; Krishnamurthy, Savitri; Lee, Hee Jin; Lee, Jeong-Yeon; Li, Yilong; McLaren, Stuart; Menzies, Andrew; Mustonen, Ville; O'Meara, Sarah; Pauporté, Iris; Pivot, Xavier; Purdie, Colin A; Raine, Keiran; Ramakrishnan, Kamna; Rodríguez-González, F Germán; Romieu, Gilles.
Afiliação
  • Nik-Zainal S; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Davies H; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK.
  • Staaf J; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Ramakrishna M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden.
  • Glodzik D; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Zou X; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Martincorena I; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Alexandrov LB; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Martin S; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Wedge DC; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA.
  • Van Loo P; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA.
  • Ju YS; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Smid M; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Brinkman AB; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Morganella S; Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium.
  • Aure MR; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Lingjærde OC; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands.
  • Langerød A; Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands.
  • Ringnér M; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.
  • Ahn SM; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway.
  • Boyault S; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway.
  • Brock JE; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway.
  • Broeks A; Department of Computer Science, University of Oslo, Oslo, Norway.
  • Butler A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway.
  • Desmedt C; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway.
  • Dirix L; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden.
  • Dronov S; Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea.
  • Fatima A; Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France.
  • Foekens JA; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
  • Gerstung M; The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • Hooijer GK; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Jang SJ; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium.
  • Jones DR; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Kim HY; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • King TA; Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
  • Krishnamurthy S; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands.
  • Lee HJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Lee JY; Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Li Y; Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea.
  • McLaren S; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Menzies A; Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea.
  • Mustonen V; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
  • O'Meara S; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA.
  • Pauporté I; Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea.
  • Pivot X; Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea.
  • Purdie CA; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Raine K; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Ramakrishnan K; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Rodríguez-González FG; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Romieu G; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Nature ; 534(7605): 47-54, 2016 06 02.
Article em En | MEDLINE | ID: mdl-27135926
ABSTRACT
We analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations. We found that 93 protein-coding cancer genes carried probable driver mutations. Some non-coding regions exhibited high mutation frequencies, but most have distinctive structural features probably causing elevated mutation rates and do not contain driver mutations. Mutational signature analysis was extended to genome rearrangements and revealed twelve base substitution and six rearrangement signatures. Three rearrangement signatures, characterized by tandem duplications or deletions, appear associated with defective homologous-recombination-based DNA repair one with deficient BRCA1 function, another with deficient BRCA1 or BRCA2 function, the cause of the third is unknown. This analysis of all classes of somatic mutation across exons, introns and intergenic regions highlights the repertoire of cancer genes and mutational processes operating, and progresses towards a comprehensive account of the somatic genetic basis of breast cancer.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Genoma Humano / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Genoma Humano / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article